Barclays PLC Insulet Corp Transaction History
Barclays PLC
- $288 Billion
- Q1 2024
A detailed history of Barclays PLC transactions in Insulet Corp stock. As of the latest transaction made, Barclays PLC holds 426,575 shares of PODD stock, worth $75.6 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
426,575
Previous 207,225
105.85%
Holding current value
$75.6 Million
Previous $45 Million
62.6%
% of portfolio
0.03%
Previous 0.02%
Shares
27 transactions
Others Institutions Holding PODD
# of Institutions
614Shares Held
62.9MCall Options Held
339KPut Options Held
916K-
Vanguard Group Inc Valley Forge, PA8.2MShares$1.45 Billion0.03% of portfolio
-
Capital Research Global Investors Los Angeles, CA7.56MShares$1.34 Billion0.3% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$1.07 Billion0.02% of portfolio
-
State Street Corp Boston, MA2.92MShares$517 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA1.99MShares$353 Million0.06% of portfolio
About INSULET CORP
- Ticker PODD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 69,403,600
- Market Cap $12.3B
- Description
- Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...